Cristcot Competitors and Similar CompaniesClear all
Cristcot's competitors and similar companies include Upsher-Smith Laboratories, Provepharm Life Solutions and LQT Therapeutics.
 Cristcot Cristcot is a life sciences company focused on drug delivery systems, combination products, and specialty drug formulations. |  Upsher-Smith Laboratories Upsher-Smith Laboratories is a pharmaceutical company providing generic and branded medications. |  Provepharm Life Solutions Provepharm Life Solutions is a life sciences research and pharmaceutical company. |  LQT Therapeutics LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias. | |
Founding Date | Founding Date 2008 | Founding Date 1919 | Founding Date 1998 | Founding Date 2019 |
Type | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Concord, US HQ Concord, US | Locations Maple Grove, US HQ Denver, US Morristown, US Plymouth, US | Locations HQ Marseille, FR | Locations Laval, CA HQ |
Employees | Employees 1427% increase | Employees 439 | Employees 1542% decrease | Employees 26 |
Funding | ||||
Latest funding round | Latest funding round $ 3m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 47.7m (about 7 years ago) | Latest funding round $ 1.4m (over 6 years ago) |
Total funding raised | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 51.4m | Total funding raised $ 1.4m |
For sources of this data, please see the company profile
View Company Profiles
Upsher-Smith Laboratories
HQ
Maple Grove, US
Upsher-Smith Laboratories is a pharmaceutical company providing generic and branded medications.
View companyProvepharm Life Solutions
HQ
Employees
154↓ 2% decrease
Provepharm Life Solutions is a life sciences research and pharmaceutical company.
View companyLQT Therapeutics
HQ
Laval, CA
Employees
26
LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias.
View company